Clinical Trial Update: Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating denosumab with pembrolizumab in clear cell renal cell carcinoma (metastatic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Kidney Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Denosumab (denosumab)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Conditions: Renal Cell Carcinoma, Clear Cell, Metastatic Kidney Cancer | Phase 2 | Status: UNKNOWN